News + Insights

Categories

23 June 2022

Biosimilars development: Successful scientific advice to accelerate development and registration

Woodley BioReg delivered successful scientific advice to accelerate biosimilars development and the registration of a biological product. Our...

Read Insight
13 May 2022

UK routes to registration for medicinal cannabis

This is the fourth and final blog in our series on medicinal cannabis. To view the others, click here....

Read Insight
13 May 2022

The medical applications of cannabis

This is the third blog in our medicinal cannabis series. You can view the first and second article here to...

Read Insight
13 May 2022

The regulatory background of medicinal cannabis in the EU and the UK

Second in our medicinal cannabis blog series, this article explores the regulatory background of medicinal cannabis in the...

Read Insight
13 May 2022

An introduction to medicinal cannabis

One of the most commonly proscribed drugs used throughout the world is cannabis. The drug has provoked both...

Read Insight
12 May 2022

Meet Alison Moore, Finance Assistant at Woodley BioReg

Can you summarise your role in one paragraph? I’m responsible for anything to do with finance and payroll...

Read Insight
09 May 2022

Healthcare regulatory affairs agency appoints senior consultant to expand reach into medical devices market

Regulatory affairs consultancy Woodley BioReg has appointed Bryan Lister as senior regulatory affairs consultant, specialising in medical devices...

Read Insight
11 April 2022

Regulatory affairs consultancy expands into Europe with launch of Italian subsidiary and office

Forms Italian business entity Woodley BioReg Srl Opens office in Milan Aims to provide seamless experience to clients...

Read Insight
08 February 2022

Trio of key appointments for regulatory affairs consultancy

Regulatory affairs consultancy, Woodley BioReg, has made three new hires in line with its global expansion plans, including...

Read Insight